Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bakhu Holdings is a biotechnology company focused on the development and commercialization of cell-based science for the production of cannabinoids. The company utilizes a proprietary platform to produce consistent, high-quality plant-derived substances without the need for traditional cultivation. By leveraging cellular agriculture, Bakhu aims to provide a sustainable and scalable source of cannabinoids for the pharmaceutical and wellness industries. Their business model involves licensing and implementing advanced bioreactor technologies to optimize the yield of specific chemical compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BKPK.